CONFERMA Trademark

Trademark Overview

On Wednesday, December 2, 2020, a trademark application was filed for CONFERMA with the United States Patent and Trademark Office. The USPTO has given the CONFERMA trademark a serial number of 79304317. The federal status of this trademark filing is REGISTERED as of Tuesday, March 8, 2022. This trademark is owned by Merck KGaA. The CONFERMA trademark is filed in the Chemical Products category with the following description:

Immunoassay reagents, other than for medical use
conferma

General Information

Serial Number79304317
Word MarkCONFERMA
Filing DateWednesday, December 2, 2020
Status700 - REGISTERED
Status DateTuesday, March 8, 2022
Registration Number6661849
Registration DateTuesday, March 8, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Goods and ServicesImmunoassay reagents, other than for medical use
Translation of Words in MarkThe English translation of the word "CONFERMA" in the mark is "CONFIRMATION".

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, February 19, 2021
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events

Event DateEvent Description
Monday, August 29, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, August 9, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, August 9, 2022FINAL DISPOSITION PROCESSED
Wednesday, June 8, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 8, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Sunday, December 19, 2021NOTIFICATION PROCESSED BY IB
Wednesday, December 1, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 1, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 11, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 29, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 29, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 24, 2021REFUSAL PROCESSED BY IB
Monday, May 3, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, May 3, 2021REFUSAL PROCESSED BY MPU
Friday, April 30, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, April 29, 2021NON-FINAL ACTION WRITTEN
Wednesday, April 28, 2021ASSIGNED TO EXAMINER
Tuesday, February 23, 2021APPLICATION FILING RECEIPT MAILED
Friday, February 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 18, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

conferma medical than other reagents immunoassay